Details for New Drug Application (NDA): 062519
✉ Email this page to a colleague
NDA 062519 describes NYSTEX, which is a drug marketed by Savage Labs and is included in one NDA. Additional details are available on the NYSTEX profile page.
The generic ingredient in NYSTEX is nystatin. There are eight drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the nystatin profile page.
The generic ingredient in NYSTEX is nystatin. There are eight drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the nystatin profile page.
Summary for 062519
| Tradename: | NYSTEX |
| Applicant: | Savage Labs |
| Ingredient: | nystatin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062519
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION;ORAL | Strength | 100,000 UNITS/ML | ||||
| Approval Date: | Jul 6, 1984 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
